CRUK Biomolecular Structure Group, The School of Pharmacy, University of London, 29-29 Brunswick Square, London WC1N 1AX, U.K.
J Med Chem. 2012 Jan 12;55(1):209-22. doi: 10.1021/jm201140v. Epub 2011 Dec 13.
The first X-ray crystal structures of nickel(II) and copper(II) salphen metal complexes bound to a quadruplex DNA are presented. Two structures have been determined and show that these salphen-metal complexes bind to human telomeric quadruplexes by end-stacking, with the metal in each case almost in line with the potassium ion channel. Quadruplex and duplex DNA binding is presented for these two and other related salphen complexes, all with side-chains terminating in pyrrolidino end-groups and differing patterns of substitution on the salphen core. The crystal structures are able to provide rationalizations for the structure-activity data, and in particular for the superior quadruplex-binding of the nickel complexes compared to that of the copper-containing ones. The complexes show significant antiproliferative activity for the compounds in a panel of cancer cell lines. They also show telomerase inhibitory activity in the telomerase TRAP-LIG assay.
首次呈现镍(II)和铜(II)席夫碱金属配合物与四链体 DNA 结合的 X 射线晶体结构。已经确定了两种结构,表明这些席夫碱-金属配合物通过末端堆积与人类端粒四链体结合,在每种情况下,金属几乎与钾离子通道成一直线。呈现了这两种和其他相关席夫碱配合物的四链体和双链体 DNA 结合,所有配合物的侧链末端都终止于吡咯烷端基,并且在席夫碱核心上具有不同的取代模式。晶体结构能够为结构-活性数据提供合理化解释,特别是对于镍配合物与含铜配合物相比具有优越的四链体结合能力。这些配合物在一系列癌细胞系的化合物中表现出显著的抗增殖活性。它们在端粒酶 TRAP-LIG 测定中也表现出端粒酶抑制活性。